Saroja Pharma Industries India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries India Limited has informed the stock exchanges that it has obtained a Certificate of Compliance under SEBI's Depositories and Participants Regulations, 2018. This regulatory document confirms that the company has fulfilled all necessary requirements for its securities to be maintained in electronic form, ensuring smooth operations for its investors.

This development is a routine administrative milestone that validates the company's adherence to market regulations. For investors, it reinforces the transparency and governance standards of the firm. While this news does not indicate a change in the company's financial performance, it provides assurance that the company is fully compliant with the rules governing its shares.

Investors should monitor the company's future quarterly reports to see how this compliance status impacts its operational efficiency. Since this is a procedural update, it is not expected to drive immediate price volatility, but it contributes to the overall credibility of the stock in the long run.